Bastiano Sanna is VP at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have made 9 open-market trades across 1 company since 2021, most recently 2023-06-01.
CIK 0001829069
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRTX | SELL · 10b5-1 | 2023-05-05 | 2023-05-09 | $350.01 | $1.3M | -1.8% | -4.4% | -0.8% |
| VRTX | SELL · 10b5-1 | 2023-05-02 | 2023-05-04 | $350.71 | $3.1M | -0.5% | -3.6% | +3.3% |
| VRTX | SELL · 10b5-1 | 2023-04-12 | 2023-04-14 | $326.70 | $4.9M | -3.5% | +4.1% | +4.2% |
| VRTX | SELL · 10b5-1 | 2023-04-04 | 2023-04-06 | $315.35 | $231K | +2.5% | +7.4% | +8.7% |
| VRTX | SELL · 10b5-1 | 2023-03-16 | 2023-03-20 | $300.59 | $1.7M | +3.7% | +9.1% | +13.9% |
| VRTX | SELL | 2023-02-14 | 2023-02-16 | $300.40 | $1.3M | -0.0% | +2.6% | +17.2% |
| VRTX | SELL · 10b5-1 | 2023-02-13 | 2023-02-14 | $300.39 | $34K | -3.9% | +0.5% | +16.6% |
| VRTX | SELL · 10b5-1 | 2023-01-31 | 2023-02-02 | $325.00 | $34K | -1.4% | -4.2% | +13.7% |
| VRTX | SELL · 10b5-1 | 2022-11-02 | 2022-11-03 | $312.64 | $100K | -2.0% | +1.9% | +1.8% |
| VRTX | SELL | 2022-10-18 | 2022-10-20 | $300.31 | $1.1M | +8.5% | +9.2% | +7.0% |
| VRTX | SELL · 10b5-1 | 2022-05-16 | 2022-05-18 | $252.83 | $11K | +6.4% | +4.2% | +20.0% |
| VRTX | SELL · 10b5-1 | 2022-05-04 | 2022-05-06 | $275.09 | $10K | +0.5% | +6.8% | +9.5% |
| VRTX | SELL · 10b5-1 | 2022-05-02 | 2022-05-04 | $259.16 | $83K | -6.4% | -0.8% | +0.8% |
| VRTX | SELL | 2022-04-07 | 2022-04-08 | $276.15 | $302K | +0.7% | -16.0% | +5.1% |
| VRTX | SELL | 2022-04-04 | 2022-04-06 | $274.10 | $2.0M | +3.7% | -6.8% | +6.1% |
| VRTX | SELL | 2022-03-17 | 2022-03-21 | $250.06 | $1.1M | +4.8% | +14.5% | +8.4% |
| VRTX | SELL | 2022-02-02 | 2022-02-03 | $250.61 | $429K | -3.3% | -2.4% | +13.4% |
| VRTX | SELL · 10b5-1 | 2021-05-17 | 2021-05-19 | $216.34 | $24K | -2.0% | -12.2% | -7.2% |
| VRTX | SELL | 2021-05-03 | 2021-05-05 | $218.43 | $419K | +1.9% | -1.1% | -5.7% |
| VRTX | SELL | 2021-04-05 | 2021-04-07 | $214.14 | $722K | +2.3% | +0.4% | -6.6% |
| VRTX | SELL | 2021-02-11 | 2021-02-16 | $210.51 | $664K | +1.4% | +1.8% | +3.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.